ADSK
67
2
COP
54
3
XEL
62
-3
CCI
30
-6
EIX
66
-3
LH
50
-5
KLAC
63
7
CHD
48
-5
TGT
52
2
BF.B
50
-7
NOV
48
3
NDAQ
63
4
EXPD
56
3
CMG
54
4
BEN
48
2
MAS
70
3
KO
47
-5
GOOG
65
2
LEN
64
3
BK
74
2
ADSK
67
2
COP
54
3
XEL
62
-3
CCI
30
-6
EIX
66
-3
LH
50
-5
KLAC
63
7
CHD
48
-5
TGT
52
2
BF.B
50
-7
NOV
48
3
NDAQ
63
4
EXPD
56
3
CMG
54
4
BEN
48
2
MAS
70
3
KO
47
-5
GOOG
65
2
LEN
64
3
BK
74
2
Financhill
Back

Akero Therapeutics Stock Predictions

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market
Buy
75

AKRO
Akero Therapeutics

Last Price:
27.48
Seasonality Move:
37.18%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm

Akero Therapeutics Stock Forecast

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 49.5% based on the past 5 years of stock performance.
  • Akero Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Akero Therapeutics Stock Undervalued?
    The current Akero Therapeutics [AKRO] share price is $28.00. The Score for AKRO is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Akero Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 49.5% based on the past 5 years of stock performance.

Akero Therapeutics Stock Rating

Buy
75
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics overpriced?

  • Akero Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Akero Therapeutics Stock Price History

Is AKRO stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com

52-Week Data

52-Week High:
51.24
52-Week Low:
11.25

Prediction Charts

Market Cap:
1.94B
Price in USD:
28.00
Volume:
468.91K
Beta:
-0.28

Technical Analysis

SMA50:
26.23
SMA100:
23.80
SMA200:
23.45
52-Wk Change:
-45.46%

Stock Predictions

  • Is Akero Therapeutics stock public?
    Yes, Akero Therapeutics is a publicly traded company.
  • What is the Akero Therapeutics stock quote today?
    The Akero Therapeutics stock price is 28.00 USD today.
  • How to buy Akero Therapeutics stock online?
    You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-30 26.95 27.20 27.50 26.32
Sep-3 27.16 26.01 28.30 25.96
Sep-4 25.71 26.30 26.41 25.31
Sep-5 26.40 26.35 26.43 25.73
Sep-6 26.56 26.44 26.96 25.67
Sep-9 26.55 26.27 27.20 25.89
Sep-10 26.18 25.74 26.18 25.01
Sep-11 25.54 25.62 25.98 25.01
Sep-12 25.69 25.70 25.84 25.20
Sep-13 26.00 27.34 27.41 25.69
Sep-16 27.40 26.77 27.69 26.73
Sep-17 27.00 26.64 27.65 26.52
Sep-18 26.72 26.96 27.81 26.26
Sep-19 28.00 28.00 28.74 27.19

Akero Therapeutics Earnings

Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Akero Therapeutics Forecast Revenue Growth

Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.73 per share, and a decrease next year of $0.56 per share.

* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.